カテゴリ： 世界, 医療/バイオ, Market Monitor Global

バイオ医薬品CDMOサービスのグローバル市場展望 2023年-2029年：革新的医薬品、上場特許医薬品、バイオシミラー等開発

■ 英語タイトル：Biopharmaceutical CDMO Service Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12270）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12270
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[バイオ医薬品CDMOサービスのグローバル市場展望 2023年-2029年：革新的医薬品、上場特許医薬品、バイオシミラー等開発]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のバイオ医薬品CDMOサービス市場規模と予測を収録しています。・世界のバイオ医薬品CDMOサービス市場：売上、2018年-2023年、2024年-2029年
・世界のバイオ医薬品CDMOサービス市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のバイオ医薬品CDMOサービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「革新的医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

バイオ医薬品CDMOサービスのグローバル主要企業は、KBI Biopharma、 INCOG BioPharma Services、 CordenPharma、 AGC Biologics、 Northway Biotech、 PlantForm Corp、 Lonza、 ADL Biopharma、 Catalent、 Future Fields、 Vetter Pharma、 Stelis、 Richter-Helm、 FUJIFILM Diosynth Biotechnologies、 Cambrex、 Pfizer CentreOne、 Samsung Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、バイオ医薬品CDMOサービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のバイオ医薬品CDMOサービス市場：タイプ別、2018年-2023年、2024年-2029年
世界のバイオ医薬品CDMOサービス市場：タイプ別市場シェア、2022年
・革新的医薬品、上場特許医薬品、バイオシミラー等開発

世界のバイオ医薬品CDMOサービス市場：用途別、2018年-2023年、2024年-2029年
世界のバイオ医薬品CDMOサービス市場：用途別市場シェア、2022年
・製薬会社、バイオ企業、その他

世界のバイオ医薬品CDMOサービス市場：地域・国別、2018年-2023年、2024年-2029年
世界のバイオ医薬品CDMOサービス市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるバイオ医薬品CDMOサービスのグローバル売上、2018年-2023年
・主要企業におけるバイオ医薬品CDMOサービスのグローバル売上シェア、2022年
・主要企業におけるバイオ医薬品CDMOサービスのグローバル販売量、2018年-2023年
・主要企業におけるバイオ医薬品CDMOサービスのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
KBI Biopharma、 INCOG BioPharma Services、 CordenPharma、 AGC Biologics、 Northway Biotech、 PlantForm Corp、 Lonza、 ADL Biopharma、 Catalent、 Future Fields、 Vetter Pharma、 Stelis、 Richter-Helm、 FUJIFILM Diosynth Biotechnologies、 Cambrex、 Pfizer CentreOne、 Samsung Biologics

*************************************************************

・調査・分析レポートの概要
バイオ医薬品CDMOサービス市場の定義
市場セグメント
世界のバイオ医薬品CDMOサービス市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のバイオ医薬品CDMOサービス市場規模
世界のバイオ医薬品CDMOサービス市場規模：2022年 VS 2029年
世界のバイオ医薬品CDMOサービス市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのバイオ医薬品CDMOサービスの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のバイオ医薬品CDMOサービス製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：革新的医薬品、上場特許医薬品、バイオシミラー等開発
バイオ医薬品CDMOサービスのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：製薬会社、バイオ企業、その他
バイオ医薬品CDMOサービスの用途別グローバル売上・予測

・地域別市場分析
地域別バイオ医薬品CDMOサービス市場規模 2022年と2029年
地域別バイオ医薬品CDMOサービス売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
KBI Biopharma、 INCOG BioPharma Services、 CordenPharma、 AGC Biologics、 Northway Biotech、 PlantForm Corp、 Lonza、 ADL Biopharma、 Catalent、 Future Fields、 Vetter Pharma、 Stelis、 Richter-Helm、 FUJIFILM Diosynth Biotechnologies、 Cambrex、 Pfizer CentreOne、 Samsung Biologics
...

This research report provides a comprehensive analysis of the Biopharmaceutical CDMO Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biopharmaceutical CDMO Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biopharmaceutical CDMO Service, challenges faced by the industry, and potential opportunities for market players.
The global Biopharmaceutical CDMO Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biopharmaceutical CDMO Service market presents opportunities for various stakeholders, including Pharmaceutical Company, Biotechnology Company. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biopharmaceutical CDMO Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biopharmaceutical CDMO Service market was valued at US$ 13810 million in 2022 and is projected to reach US$ 28990 million by 2029, at a CAGR of 10.8% during the forecast period.
Key Features:
The research report on the Biopharmaceutical CDMO Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biopharmaceutical CDMO Service market.
Market Overview: The report provides a comprehensive overview of the Biopharmaceutical CDMO Service market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Develop Innovative Drugs, Listed Patented Drug), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biopharmaceutical CDMO Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biopharmaceutical CDMO Service market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biopharmaceutical CDMO Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biopharmaceutical CDMO Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biopharmaceutical CDMO Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biopharmaceutical CDMO Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biopharmaceutical CDMO Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biopharmaceutical CDMO Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biopharmaceutical CDMO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others
Market segment by Application
Pharmaceutical Company
Biotechnology Company
Others
Global Biopharmaceutical CDMO Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biopharmaceutical CDMO Service, market overview.
Chapter 2: Global Biopharmaceutical CDMO Service market size in revenue.
Chapter 3: Detailed analysis of Biopharmaceutical CDMO Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biopharmaceutical CDMO Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Biopharmaceutical CDMO Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceutical CDMO Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceutical CDMO Service Overall Market Size
2.1 Global Biopharmaceutical CDMO Service Market Size: 2022 VS 2029
2.2 Global Biopharmaceutical CDMO Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceutical CDMO Service Players in Global Market
3.2 Top Global Biopharmaceutical CDMO Service Companies Ranked by Revenue
3.3 Global Biopharmaceutical CDMO Service Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceutical CDMO Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biopharmaceutical CDMO Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceutical CDMO Service Players in Global Market
3.6.1 List of Global Tier 1 Biopharmaceutical CDMO Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceutical CDMO Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Biopharmaceutical CDMO Service Market Size Markets, 2022 & 2029
4.1.2 Develop Innovative Drugs
4.1.3 Listed Patented Drug
4.1.4 Biosimilars
4.1.5 Others
4.2 By Type – Global Biopharmaceutical CDMO Service Revenue & Forecasts
4.2.1 By Type – Global Biopharmaceutical CDMO Service Revenue, 2018-2023
4.2.2 By Type – Global Biopharmaceutical CDMO Service Revenue, 2024-2029
4.2.3 By Type – Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biopharmaceutical CDMO Service Market Size, 2022 & 2029
5.1.2 Pharmaceutical Company
5.1.3 Biotechnology Company
5.1.4 Others
5.2 By Application – Global Biopharmaceutical CDMO Service Revenue & Forecasts
5.2.1 By Application – Global Biopharmaceutical CDMO Service Revenue, 2018-2023
5.2.2 By Application – Global Biopharmaceutical CDMO Service Revenue, 2024-2029
5.2.3 By Application – Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Biopharmaceutical CDMO Service Market Size, 2022 & 2029
6.2 By Region – Global Biopharmaceutical CDMO Service Revenue & Forecasts
6.2.1 By Region – Global Biopharmaceutical CDMO Service Revenue, 2018-2023
6.2.2 By Region – Global Biopharmaceutical CDMO Service Revenue, 2024-2029
6.2.3 By Region – Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Biopharmaceutical CDMO Service Revenue, 2018-2029
6.3.2 US Biopharmaceutical CDMO Service Market Size, 2018-2029
6.3.3 Canada Biopharmaceutical CDMO Service Market Size, 2018-2029
6.3.4 Mexico Biopharmaceutical CDMO Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Biopharmaceutical CDMO Service Revenue, 2018-2029
6.4.2 Germany Biopharmaceutical CDMO Service Market Size, 2018-2029
6.4.3 France Biopharmaceutical CDMO Service Market Size, 2018-2029
6.4.4 U.K. Biopharmaceutical CDMO Service Market Size, 2018-2029
6.4.5 Italy Biopharmaceutical CDMO Service Market Size, 2018-2029
6.4.6 Russia Biopharmaceutical CDMO Service Market Size, 2018-2029
6.4.7 Nordic Countries Biopharmaceutical CDMO Service Market Size, 2018-2029
6.4.8 Benelux Biopharmaceutical CDMO Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Biopharmaceutical CDMO Service Revenue, 2018-2029
6.5.2 China Biopharmaceutical CDMO Service Market Size, 2018-2029
6.5.3 Japan Biopharmaceutical CDMO Service Market Size, 2018-2029
6.5.4 South Korea Biopharmaceutical CDMO Service Market Size, 2018-2029
6.5.5 Southeast Asia Biopharmaceutical CDMO Service Market Size, 2018-2029
6.5.6 India Biopharmaceutical CDMO Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Biopharmaceutical CDMO Service Revenue, 2018-2029
6.6.2 Brazil Biopharmaceutical CDMO Service Market Size, 2018-2029
6.6.3 Argentina Biopharmaceutical CDMO Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Biopharmaceutical CDMO Service Revenue, 2018-2029
6.7.2 Turkey Biopharmaceutical CDMO Service Market Size, 2018-2029
6.7.3 Israel Biopharmaceutical CDMO Service Market Size, 2018-2029
6.7.4 Saudi Arabia Biopharmaceutical CDMO Service Market Size, 2018-2029
6.7.5 UAE Biopharmaceutical CDMO Service Market Size, 2018-2029
7 Biopharmaceutical CDMO Service Companies Profiles
7.1 KBI Biopharma
7.1.1 KBI Biopharma Company Summary
7.1.2 KBI Biopharma Business Overview
7.1.3 KBI Biopharma Biopharmaceutical CDMO Service Major Product Offerings
7.1.4 KBI Biopharma Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.1.5 KBI Biopharma Key News & Latest Developments
7.2 INCOG BioPharma Services
7.2.1 INCOG BioPharma Services Company Summary
7.2.2 INCOG BioPharma Services Business Overview
7.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Major Product Offerings
7.2.4 INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.2.5 INCOG BioPharma Services Key News & Latest Developments
7.3 CordenPharma
7.3.1 CordenPharma Company Summary
7.3.2 CordenPharma Business Overview
7.3.3 CordenPharma Biopharmaceutical CDMO Service Major Product Offerings
7.3.4 CordenPharma Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.3.5 CordenPharma Key News & Latest Developments
7.4 AGC Biologics
7.4.1 AGC Biologics Company Summary
7.4.2 AGC Biologics Business Overview
7.4.3 AGC Biologics Biopharmaceutical CDMO Service Major Product Offerings
7.4.4 AGC Biologics Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.4.5 AGC Biologics Key News & Latest Developments
7.5 Northway Biotech
7.5.1 Northway Biotech Company Summary
7.5.2 Northway Biotech Business Overview
7.5.3 Northway Biotech Biopharmaceutical CDMO Service Major Product Offerings
7.5.4 Northway Biotech Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.5.5 Northway Biotech Key News & Latest Developments
7.6 PlantForm Corp
7.6.1 PlantForm Corp Company Summary
7.6.2 PlantForm Corp Business Overview
7.6.3 PlantForm Corp Biopharmaceutical CDMO Service Major Product Offerings
7.6.4 PlantForm Corp Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.6.5 PlantForm Corp Key News & Latest Developments
7.7 Lonza
7.7.1 Lonza Company Summary
7.7.2 Lonza Business Overview
7.7.3 Lonza Biopharmaceutical CDMO Service Major Product Offerings
7.7.4 Lonza Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.7.5 Lonza Key News & Latest Developments
7.8 ADL Biopharma
7.8.1 ADL Biopharma Company Summary
7.8.2 ADL Biopharma Business Overview
7.8.3 ADL Biopharma Biopharmaceutical CDMO Service Major Product Offerings
7.8.4 ADL Biopharma Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.8.5 ADL Biopharma Key News & Latest Developments
7.9 Catalent
7.9.1 Catalent Company Summary
7.9.2 Catalent Business Overview
7.9.3 Catalent Biopharmaceutical CDMO Service Major Product Offerings
7.9.4 Catalent Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.9.5 Catalent Key News & Latest Developments
7.10 Future Fields
7.10.1 Future Fields Company Summary
7.10.2 Future Fields Business Overview
7.10.3 Future Fields Biopharmaceutical CDMO Service Major Product Offerings
7.10.4 Future Fields Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.10.5 Future Fields Key News & Latest Developments
7.11 Vetter Pharma
7.11.1 Vetter Pharma Company Summary
7.11.2 Vetter Pharma Business Overview
7.11.3 Vetter Pharma Biopharmaceutical CDMO Service Major Product Offerings
7.11.4 Vetter Pharma Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.11.5 Vetter Pharma Key News & Latest Developments
7.12 Stelis
7.12.1 Stelis Company Summary
7.12.2 Stelis Business Overview
7.12.3 Stelis Biopharmaceutical CDMO Service Major Product Offerings
7.12.4 Stelis Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.12.5 Stelis Key News & Latest Developments
7.13 Richter-Helm
7.13.1 Richter-Helm Company Summary
7.13.2 Richter-Helm Business Overview
7.13.3 Richter-Helm Biopharmaceutical CDMO Service Major Product Offerings
7.13.4 Richter-Helm Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.13.5 Richter-Helm Key News & Latest Developments
7.14 FUJIFILM Diosynth Biotechnologies
7.14.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.14.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Major Product Offerings
7.14.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.14.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.15 Cambrex
7.15.1 Cambrex Company Summary
7.15.2 Cambrex Business Overview
7.15.3 Cambrex Biopharmaceutical CDMO Service Major Product Offerings
7.15.4 Cambrex Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.15.5 Cambrex Key News & Latest Developments
7.16 Pfizer CentreOne
7.16.1 Pfizer CentreOne Company Summary
7.16.2 Pfizer CentreOne Business Overview
7.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Major Product Offerings
7.16.4 Pfizer CentreOne Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.16.5 Pfizer CentreOne Key News & Latest Developments
7.17 Samsung Biologics
7.17.1 Samsung Biologics Company Summary
7.17.2 Samsung Biologics Business Overview
7.17.3 Samsung Biologics Biopharmaceutical CDMO Service Major Product Offerings
7.17.4 Samsung Biologics Biopharmaceutical CDMO Service Revenue in Global Market (2018-2023)
7.17.5 Samsung Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Biopharmaceutical CDMO Service Market Opportunities & Trends in Global Market
Table 2. Biopharmaceutical CDMO Service Market Drivers in Global Market
Table 3. Biopharmaceutical CDMO Service Market Restraints in Global Market
Table 4. Key Players of Biopharmaceutical CDMO Service in Global Market
Table 5. Top Biopharmaceutical CDMO Service Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biopharmaceutical CDMO Service Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biopharmaceutical CDMO Service Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biopharmaceutical CDMO Service Product Type
Table 9. List of Global Tier 1 Biopharmaceutical CDMO Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical CDMO Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biopharmaceutical CDMO Service Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biopharmaceutical CDMO Service Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biopharmaceutical CDMO Service Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biopharmaceutical CDMO Service Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biopharmaceutical CDMO Service Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biopharmaceutical CDMO Service Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2024-2029
Table 30. KBI Biopharma Company Summary
Table 31. KBI Biopharma Biopharmaceutical CDMO Service Product Offerings
Table 32. KBI Biopharma Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 33. KBI Biopharma Key News & Latest Developments
Table 34. INCOG BioPharma Services Company Summary
Table 35. INCOG BioPharma Services Biopharmaceutical CDMO Service Product Offerings
Table 36. INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 37. INCOG BioPharma Services Key News & Latest Developments
Table 38. CordenPharma Company Summary
Table 39. CordenPharma Biopharmaceutical CDMO Service Product Offerings
Table 40. CordenPharma Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 41. CordenPharma Key News & Latest Developments
Table 42. AGC Biologics Company Summary
Table 43. AGC Biologics Biopharmaceutical CDMO Service Product Offerings
Table 44. AGC Biologics Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 45. AGC Biologics Key News & Latest Developments
Table 46. Northway Biotech Company Summary
Table 47. Northway Biotech Biopharmaceutical CDMO Service Product Offerings
Table 48. Northway Biotech Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 49. Northway Biotech Key News & Latest Developments
Table 50. PlantForm Corp Company Summary
Table 51. PlantForm Corp Biopharmaceutical CDMO Service Product Offerings
Table 52. PlantForm Corp Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 53. PlantForm Corp Key News & Latest Developments
Table 54. Lonza Company Summary
Table 55. Lonza Biopharmaceutical CDMO Service Product Offerings
Table 56. Lonza Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 57. Lonza Key News & Latest Developments
Table 58. ADL Biopharma Company Summary
Table 59. ADL Biopharma Biopharmaceutical CDMO Service Product Offerings
Table 60. ADL Biopharma Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 61. ADL Biopharma Key News & Latest Developments
Table 62. Catalent Company Summary
Table 63. Catalent Biopharmaceutical CDMO Service Product Offerings
Table 64. Catalent Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 65. Catalent Key News & Latest Developments
Table 66. Future Fields Company Summary
Table 67. Future Fields Biopharmaceutical CDMO Service Product Offerings
Table 68. Future Fields Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 69. Future Fields Key News & Latest Developments
Table 70. Vetter Pharma Company Summary
Table 71. Vetter Pharma Biopharmaceutical CDMO Service Product Offerings
Table 72. Vetter Pharma Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 73. Vetter Pharma Key News & Latest Developments
Table 74. Stelis Company Summary
Table 75. Stelis Biopharmaceutical CDMO Service Product Offerings
Table 76. Stelis Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 77. Stelis Key News & Latest Developments
Table 78. Richter-Helm Company Summary
Table 79. Richter-Helm Biopharmaceutical CDMO Service Product Offerings
Table 80. Richter-Helm Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 81. Richter-Helm Key News & Latest Developments
Table 82. FUJIFILM Diosynth Biotechnologies Company Summary
Table 83. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Offerings
Table 84. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 85. FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
Table 86. Cambrex Company Summary
Table 87. Cambrex Biopharmaceutical CDMO Service Product Offerings
Table 88. Cambrex Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 89. Cambrex Key News & Latest Developments
Table 90. Pfizer CentreOne Company Summary
Table 91. Pfizer CentreOne Biopharmaceutical CDMO Service Product Offerings
Table 92. Pfizer CentreOne Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 93. Pfizer CentreOne Key News & Latest Developments
Table 94. Samsung Biologics Company Summary
Table 95. Samsung Biologics Biopharmaceutical CDMO Service Product Offerings
Table 96. Samsung Biologics Biopharmaceutical CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 97. Samsung Biologics Key News & Latest Developments
List of Figures
Figure 1. Biopharmaceutical CDMO Service Segment by Type in 2022
Figure 2. Biopharmaceutical CDMO Service Segment by Application in 2022
Figure 3. Global Biopharmaceutical CDMO Service Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical CDMO Service Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biopharmaceutical CDMO Service Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceutical CDMO Service Revenue in 2022
Figure 8. By Type - Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 16. US Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 20. Germany Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 21. France Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 28. China Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 32. India Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 34. Brazil Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biopharmaceutical CDMO Service Revenue Market Share, 2018-2029
Figure 37. Turkey Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biopharmaceutical CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 41. KBI Biopharma Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. CordenPharma Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AGC Biologics Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Northway Biotech Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. PlantForm Corp Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Lonza Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ADL Biopharma Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Catalent Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Future Fields Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Vetter Pharma Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Stelis Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Richter-Helm Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Cambrex Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Pfizer CentreOne Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Samsung Biologics Biopharmaceutical CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • バイオ医薬品サービスのグローバル市場展望 2023年-2029年：原材料、製造工程・製品、医薬品完成品、その他
  • 低分子CDMOのグローバル市場展望 2023年-2029年：開発、原薬製造
  • バイオ医薬品用3PL（サードパーティーロジスティクス）のグローバル市場（2022年-2029年）：コールドチェーン、非コールドチェーン
  • 創傷治療用ジェルのグローバル市場展望 2023年-2029年：皮膚感染症用ジェル、表面創傷用ジェル、その他
  • 閉経後骨粗鬆症治療薬のグローバル市場展望 2023年-2029年：経口式、皮下注射、静脈注射、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12270 )"バイオ医薬品CDMOサービスのグローバル市場展望 2023年-2029年：革新的医薬品、上場特許医薬品、バイオシミラー等開発" (英文：Biopharmaceutical CDMO Service Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。